| Ytd | -29.20% | |
| 1y | 221.48% |
| Open | 4.37 | Prev Close | 4.37 | Low | 4.17 | High | 4.53 | Mkt Cap | 225.36M |
| Vol | 146.14K | Avg Vol | 157.49K | EPS | -2.35 | P/E | N/A | Forward P/E | -2.52 |
| Beta | 1.89 | Short Ratio | 2.72 | Inst. Own | 42.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 4.26 | 200-d Avg | 4.33 | 1yr Est | 19.91 |
CAMP News
Top analysts changed ratings on top names, including Sunrun, enGene Therapeutics, Camp4 Therapeutics
Top analysts upgraded XOM, CAMP, EXR, WPC, and KRC stocks, with price targets ranging from $44 to $1
JP Morgan analyst Anupam Rama upgrades Camp4 Therapeutics (NASDAQ:CAMP) from Neutral to Overweigh
Chardan Capital analyst Keay Nakae initiates coverage on Camp4 Therapeutics (NASDAQ:CAMP) with a
Camp4 Therapeutics (NASDAQ:CAMP) reported quarterly losses of $(0.32) per share which missed the ana
Using epigenomic mapping and regulatory RNA (regRNA) Capture-seq, CAMP4 has assembled what it believ
Rodman & Renshaw analyst Seema Sheoran initiates coverage on Camp4 Therapeutics (NASDAQ:CAMP)
Wall Street analysts changed outlook on top names. See complete view of rating changes, including up
Leerink Partners analyst Mani Foroohar maintains Camp4 Therapeutics (NASDAQ:CAMP) with a Outperfo
Camp4 Therapeutics (NASDAQ:CAMP) reported quarterly losses of $(0.87) per share which missed the ana
CAMP4 signs ASO collaboration with GSK, securing $17.5 million upfront as analysts reaffirm Outperfo
Collaboration to leverage CAMP4's RAP Platform® to accelerate development of novel antisense oli
CAMP4 Therapeutics Corporation ("CAMP4" or the "Company") (NASDAQ:CAMP), a clinical-
Camp4 Therapeutics (NASDAQ:CAMP) reported quarterly losses of $(0.55) per share which beat the analy
Cantor Fitzgerald analyst Steve Seedhouse initiates coverage on Camp4 Therapeutics (NASDAQ:CAMP)
Piper Sandler analyst Edward Tenthoff maintains Camp4 Therapeutics (NASDAQ:CAMP) with a Overweigh
Oversubscribed Financing led by Coastlands Capital with participation from new and existing investor
Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session f
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading.
Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group an
During Tuesday's session, 275 companies made new 52-week lows.
Wednesday's session saw 150 companies set new 52-week lows.
On Tuesday, 210 companies reached new 52-week lows.
During Monday's session, 201 stocks hit new 52-week lows.
During the Friday's sesion, 157 stocks hit new 52-week lows.
On Wednesday, 155 companies set new 52-week lows.
On Monday, 120 stocks hit new 52-week lows.
On Friday, 199 companies reached new 52-week lows.
On Thursday, 498 companies reached new 52-week lows.
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its f
On Wednesday, 345 companies set new 52-week lows.